Glutathione IV Therapy for Aging and Chronic Diseases As we age, glutathione levels naturally decline, leading to increased vulnerability to age-related diseases
Research suggests BPC-157 upregulates growth hormone receptor expression on tendon fibroblasts, potentially amplifying the tissue-building signals that drive repair
Tesamorelin binds to GHRH receptors on the pituitary gland, which triggers a natural, pulsed release of growth hormone
Recently, I attended a webinar from my FDN schools graduate education program featuring Dr
In one trial, about 66 per cent of people on trizepatide lost more than 10 per cent of their body weight in one year, compared to 41 per cent on semaglutide
GLP-1 receptor agonists, such as semaglutide (sold under the brand name Ozempic or Wegovy) and tirzepatide (brand name Mounjaro or Zepbound), are medications originally developed for diabetes and now approved for chronic weight management at specific doses